"Idiopathic" livedoid vasculitis;Atrophie blanche «idiopathique»

Annales de Dermatologie et de Venereologie

Volumn 128, Issue 10 I, 2001, Pages 1003-1007

  Tran, M D ^a   Becherel P A ^a   Cordel, N ^a   Piette, J C ^a   Frances C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN ANTIBODY; FIBRINOGEN; HOMOCYSTEINE; PHOSPHOLIPID ANTIBODY; PROTHROMBIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FIBRINOLYSIS; GENE MUTATION; HUMAN; HYPERHOMOCYSTEINEMIA; IDIOPATHIC DISEASE; MALE; THROMBOCYTE AGGREGATION; THROMBOPHILIA; THROMBOSIS; VASCULITIS; MIDDLE AGED; PATHOLOGY; SKIN BLOOD VESSEL DISORDER;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; SKIN DISEASES, VASCULAR;

EID: 0035496716     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Livedo vasculitis: Segmental hyalinizing vasculitis of the dermis
2. Atrophie blanche: Periodic painful ulcers of the lower extremities
3. A peripheral vascular syndrome overlapping with systemic lupus erythematosus
4. Unexplained thrombosis and factor V mutation
5. The heterozygous 20210G/A prothrombine genotype is associated with early venous thrombosis in inherited thrombophilia and is not increased in frequency in arterial disease
6. L'atrophie blanche idiopathique cause de microangiopathie cutanée thrombosante
7. Idiopathic atrophie blanche
8. Cutaneous manifestations of Hughes syndrome occurring in the context of lupus erythematosus
9. Thrombotic skin disease as a marker of the anticardiolipin syndrome: Livedo vasculitis and distal gangrene associated with abnormal serum antiphospholipid activity
10. Livedoid vasculitis: A manifestation of the antiphospholipid syndrome?
11. Livedo vasculitis with protein C system deficiency
12. Antithrombotic treatment in livedo vasculitis
13. Livedo vasculitis: Vasculitis or thrombotic vasculopathy?
14. Apport de la génétique moléculaire dans les anomalies responsables de la thrombose
15. Thrombophilia genotypes in subjects with idiopathic antiphospholipid antibodies and significance
16. Factor V Leiden and risks of recurrent idiopathic venous thromboembolism
17. Resistance to activated protein C and FV Leiden mutation in patients with history of acute myocardial infarction or primary hypertension
18. Mutation du facteur V dans le syndrome de Sneddon
19. Effect of the factor V Leiden mutation on the severity of meningoccoccal disease
20. Cryofibrinogaenemia: A study of 49 patients
21. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S
22. Thrombophilia as a multigenic disease
23. Clinical study of livedoid vasculitis
24. Fibrinolytic therapy for vasculitis of atrophie blanche
25. Minidose heparin therapy for vasculitis of atrophie blanche
26. Livedo vasculitis: Therapy with pentoxifylline
27. Tissue plasminogen activator for treatment of livedoid vasculitis
28. Successful treatment of ulcerating livedo reticularis with infusion of prostacyclin
29. Livedoid vasculitis: Response to low-dose danazol
30. Vascularite livédoïde: À propos d'un cas